                         SEQUENCE LISTING

<110>  BicycleTx Limited
 
<120>  ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS

<130>  BIC-C-P2973PCT

<150>  US 63/135,161
<151>  2021-01-08

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  1

Cys His Lys Phe Pro Cys Arg Asp Pro Gln Gln Tyr Leu Phe Cys 
1               5                   10                  15  


<210>  2
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  2

Cys Thr Ser Pro Met Cys Tyr Val Leu Lys His Gln Asn Arg Cys 
1               5                   10                  15  


<210>  3
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  3

Cys Thr Arg Pro Trp Cys His Ser Leu Leu Pro Arg Ala Thr Cys 
1               5                   10                  15  


<210>  4
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  4

Cys Gly Arg Gln Phe Cys His Thr Leu Met Pro Arg His Leu Cys 
1               5                   10                  15  


<210>  5
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  5

Cys Val Arg Ser His Cys Ser Ser Leu Leu Pro Arg Ile His Cys 
1               5                   10                  15  


<210>  6
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  6

Cys Gly Arg Glu Glu Leu Pro Cys Arg Ile Lys Leu Cys 
1               5                   10              


<210>  7
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  7

Cys Leu Arg Ser Tyr Asn Leu Cys Pro Arg Ile Asn Cys 
1               5                   10              


<210>  8
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  8

Cys His Arg Asp Phe Pro Arg Cys Thr Trp Glu Thr Gln Trp Cys 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  9

Cys Ala Pro Ile Leu Cys Arg Trp Ala Glu Arg Gln Gly Tyr Cys 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  10

Cys Asn Ala Val Leu Cys Ser Trp Ala Arg Ala Asn Ser Phe Cys 
1               5                   10                  15  


<210>  11
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide


<220>
<221>  Xaa
<222>  (8)..(8)
<223>  Xaa is 1Nal

<400>  11

Cys Asn Ala Val Leu Cys Ser Xaa Ala Arg Ala Asn Ser Phe Cys 
1               5                   10                  15  


<210>  12
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide


<220>
<221>  Xaa
<222>  (8)..(8)
<223>  Xaa is 2Nal

<400>  12

Cys Asn Ala Val Leu Cys Ser Xaa Ala Arg Ala Asn Ser Phe Cys 
1               5                   10                  15  


<210>  13
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide


<220>
<221>  Xaa
<222>  (9)..(9)
<223>  Xaa is Aib

<400>  13

Cys Asn Ala Val Leu Cys Ser Trp Xaa Arg Ala Asn Ser Phe Cys 
1               5                   10                  15  


<210>  14
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide


<220>
<221>  Xaa
<222>  (10)..(10)
<223>  Xaa is HArg

<400>  14

Cys Asn Ala Val Leu Cys Ser Trp Ala Xaa Ala Asn Ser Phe Cys 
1               5                   10                  15  


<210>  15
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  15

Cys Leu Glu Leu Tyr Gln Cys Trp Arg Gly Lys Cys 
1               5                   10          


<210>  16
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  16

Cys Pro Ser Gln Tyr Lys Cys Trp Arg Gly Lys Cys 
1               5                   10          


<210>  17
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide

<400>  17

Cys Leu Glu Val Tyr Lys Cys Trp Arg Gly Lys Cys 
1               5                   10          


<210>  18
<211>  16
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide


<220>
<221>  Xaa
<222>  (4)..(4)
<223>  Xaa is Aib

<400>  18

Cys Ala Asn Xaa Val Leu Cys Ser Trp Ala Arg Ala Asn Ser Phe Cys 
1               5                   10                  15      


<210>  19
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic Peptide


<220>
<221>  Xaa
<222>  (14)..(14)
<223>  Xaa is Agb

<400>  19

Cys Asn Ser Tyr Thr Cys Tyr Ile Lys His Ile Leu Gly Xaa Cys 
1               5                   10                  15  


